296 related articles for article (PubMed ID: 26728896)
1. Dual modulation of Ras-Mnk and PI3K-AKT-mTOR pathways: A Novel c-FLIP inhibitory mechanism of 3-AWA mediated translational attenuation through dephosphorylation of eIF4E.
ur Rasool R; Rah B; Amin H; Nayak D; Chakraborty S; Rawoof A; Mintoo MJ; Yousuf K; Mukherjee D; Kumar LD; Mondhe DM; Goswami A
Sci Rep; 2016 Jan; 6():18800. PubMed ID: 26728896
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of eIF4E by MNKs supports protein synthesis, cell cycle progression and proliferation in prostate cancer cells.
Bianchini A; Loiarro M; Bielli P; Busà R; Paronetto MP; Loreni F; Geremia R; Sette C
Carcinogenesis; 2008 Dec; 29(12):2279-88. PubMed ID: 18809972
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation.
Wang X; Yue P; Chan CB; Ye K; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Fu H; Khuri FR; Sun SY
Mol Cell Biol; 2007 Nov; 27(21):7405-13. PubMed ID: 17724079
[TBL] [Abstract][Full Text] [Related]
4. RhoE inhibits 4E-BP1 phosphorylation and eIF4E function impairing cap-dependent translation.
Villalonga P; Fernández de Mattos S; Ridley AJ
J Biol Chem; 2009 Dec; 284(51):35287-96. PubMed ID: 19850923
[TBL] [Abstract][Full Text] [Related]
5. 4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras proto-oncogenes in mice.
Wang C; Cigliano A; Jiang L; Li X; Fan B; Pilo MG; Liu Y; Gui B; Sini M; Smith JW; Dombrowski F; Calvisi DF; Evert M; Chen X
Hepatology; 2015 Jan; 61(1):200-13. PubMed ID: 25145583
[TBL] [Abstract][Full Text] [Related]
6. Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E.
Li Y; Yue P; Deng X; Ueda T; Fukunaga R; Khuri FR; Sun SY
Neoplasia; 2010 Oct; 12(10):848-55. PubMed ID: 20927323
[TBL] [Abstract][Full Text] [Related]
7. TGFβ-induced PI 3 kinase-dependent Mnk-1 activation is necessary for Ser-209 phosphorylation of eIF4E and mesangial cell hypertrophy.
Das F; Ghosh-Choudhury N; Bera A; Kasinath BS; Choudhury GG
J Cell Physiol; 2013 Jul; 228(7):1617-26. PubMed ID: 23359369
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of eukaryotic translation initiation factor 4E and eukaryotic translation initiation factor 4E-binding protein (4EBP) and their upstream signaling components undergo diurnal oscillation in the mouse hippocampus: implications for memory persistence.
Saraf A; Luo J; Morris DR; Storm DR
J Biol Chem; 2014 Jul; 289(29):20129-38. PubMed ID: 24895127
[TBL] [Abstract][Full Text] [Related]
9. Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma.
Demosthenous C; Han JJ; Stenson MJ; Maurer MJ; Wellik LE; Link B; Hege K; Dogan A; Sotomayor E; Witzig T; Gupta M
Oncotarget; 2015 Apr; 6(11):9488-501. PubMed ID: 25839159
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus NS5A binds to the mRNA cap-binding eukaryotic translation initiation 4F (eIF4F) complex and up-regulates host translation initiation machinery through eIF4E-binding protein 1 inactivation.
George A; Panda S; Kudmulwar D; Chhatbar SP; Nayak SC; Krishnan HH
J Biol Chem; 2012 Feb; 287(7):5042-58. PubMed ID: 22184107
[TBL] [Abstract][Full Text] [Related]
11. FOXD1-AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway.
Wu Q; Ma J; Wei J; Meng W; Wang Y; Shi M
Mol Oncol; 2021 Jan; 15(1):299-316. PubMed ID: 32460412
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of phosphatidylinositol 3-kinase- and ERK MAPK-regulated protein synthesis reveals the pro-apoptotic properties of CD40 ligation in carcinoma cells.
Davies CC; Mason J; Wakelam MJ; Young LS; Eliopoulos AG
J Biol Chem; 2004 Jan; 279(2):1010-9. PubMed ID: 14581487
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of global translation to mTOR inhibition in REN cells depends on the equilibrium between eIF4E and 4E-BP1.
Grosso S; Pesce E; Brina D; Beugnet A; Loreni F; Biffo S
PLoS One; 2011; 6(12):e29136. PubMed ID: 22216185
[TBL] [Abstract][Full Text] [Related]
14. Modulation of 4E-BP1 function as a critical determinant of enzastaurin-induced apoptosis.
Dumstorf CA; Konicek BW; McNulty AM; Parsons SH; Furic L; Sonenberg N; Graff JR
Mol Cancer Ther; 2010 Dec; 9(12):3158-63. PubMed ID: 20971826
[TBL] [Abstract][Full Text] [Related]
15. The synergistic inhibition of breast cancer proliferation by combined treatment with 4EGI-1 and MK2206.
Wang H; Huang F; Wang J; Wang P; Lv W; Hong L; Li S; Zhou J
Cell Cycle; 2015; 14(2):232-42. PubMed ID: 25607647
[TBL] [Abstract][Full Text] [Related]
16. ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer.
Ye Q; Cai W; Zheng Y; Evers BM; She QB
Oncogene; 2014 Apr; 33(14):1828-39. PubMed ID: 23624914
[TBL] [Abstract][Full Text] [Related]
17. Targeting Mnks for cancer therapy.
Hou J; Lam F; Proud C; Wang S
Oncotarget; 2012 Feb; 3(2):118-31. PubMed ID: 22392765
[TBL] [Abstract][Full Text] [Related]
18. CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway.
Wen Q; Wang W; Luo J; Chu S; Chen L; Xu L; Zang H; Alnemah MM; Ma J; Fan S
Oncotarget; 2016 May; 7(19):27787-801. PubMed ID: 27050281
[TBL] [Abstract][Full Text] [Related]
19. The eIF4E/eIF4G interaction inhibitor 4EGI-1 augments TRAIL-mediated apoptosis through c-FLIP Down-regulation and DR5 induction independent of inhibition of cap-dependent protein translation.
Fan S; Li Y; Yue P; Khuri FR; Sun SY
Neoplasia; 2010 Apr; 12(4):346-56. PubMed ID: 20360945
[TBL] [Abstract][Full Text] [Related]
20. Translational control of the antiapoptotic function of Ras.
Polunovsky VA; Gingras AC; Sonenberg N; Peterson M; Tan A; Rubins JB; Manivel JC; Bitterman PB
J Biol Chem; 2000 Aug; 275(32):24776-80. PubMed ID: 10811643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
